Skip to main content
Clinical Trials/NCT05643365
NCT05643365RecruitingNot Applicable

Factors Affecting Timing of Hypothyroidism Following Radioactive Iodine Therapy Patients With Graves Disease

Assiut University1 site in 1 country300 target enrollmentStarted: January 1, 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
300
Locations
1
Primary Endpoint
predictive factors of early hypothyroidism after RAI therapy

Study Overview

Brief Summary

The purpose of this retrospective study was to clarify the possible risk factors of early hypothyroidism after RAI therapy in Graves' disease.

Detailed Description

Hyperthyroidism is a clinical syndrome caused by increased thyroid hormone in the blood, it can lead to multiple complications, including cardiac, hepatic, and hematologic system complications. More than 80% of hyperthyroidism are caused by Graves' disease (GD). 3% of women and 0.5% of men may suffer GD in their lifetime [1].

Radioactive iodine (RAI) therapy is an important treatment option for Graves' disease (GD), the main side effect of RAI treatment is hypothyroidism, and the factors resulting in hypothyroidism are still controversial [2]. Male gender, smaller thyroid weight, higher thyroid-stimulating hormone, and smaller thyroid volume are Suggested to be the main risk factors for early hypothyroidism [2]-[3].

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Other

Eligibility Criteria

Ages
13 Years to 70 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Graves' disease patients after one year of RAI therapy .
  • Suppressed serum thyrotropin (TSH) <0.55 µU/ml , elevated serum free triiodothyronine (FT3) > 6.5 pmol/L , free thyroxin FT4 >22.7 pmol/L .

Exclusion Criteria

  • Patients with other causes of hyperthyroidism , such as toxic multinodular goiter and single toxic adenoma
  • Thyroid cancer
  • Recurrent GD
  • Previous Thyroid surgery
  • Patients can't complete the follow -up within 6 months.

Outcomes

Primary Outcomes

predictive factors of early hypothyroidism after RAI therapy

Time Frame: 1 year

Retrospective study from 2013 to 2022 to analyze the correlation between clinical, demographic\& and laboratory data and incidence of hypothyroidism by measuring thyroid function tests

Secondary Outcomes

  • the incidence of hypothyroidism within 1 year(10 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Aya Abdel-Baset Ahmed Ali Alsanory

Resident in nuclear medicine departement (South Egypt Cancer institute)

Assiut University

Study Sites (1)

Loading locations...

Similar Trials